CBI comments on proposed takeover of AstraZeneca by Pfizer…
The CBI today commented on a proposed takeover of AstraZeneca by Pfizer.
John Cridland, CBI Director-General, said:
“The most important issue for British business with this proposed takeover is the strength of the UK scientific research base of which pharma is a critical part.
“Open markets are an asset for the UK and the CBI does not support protectionism.
“This offer is primarily a decision for the board and shareholders of AstraZeneca.
“If a proposed takeover proceeds, it would be vital for the UK Government to receive assurances about the maintenance of research activity in the UK which sustain over time.”
Go to the main page
Tags: AstraZeneca by Pfizer, birmingham business news, Birmingham Events, Birmingham News, Business How to guides, Business Information Portal, CBI, graduate recruitment, John Cridland, National, The BIP, West Midlands Business News, West Midlands News